The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Anti-Infective Drugs market was valued at US$ 215340 million in 2023 and is anticipated to reach US$ 272130 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Drugs.
Report Scope
The Anti-Infective Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infective Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis AG
- Gilead Sciences
- Abbott
- Sanofi-Aventis
- Bristol-Myers Squibb
- Johnson
- Roche Pharma AG
- Nanosphere
- NanoViricides
- Novabay Pharmaceuticals
- Obetech
- Optimer Pharmaceuticals
- Basilea Pharmaceutica AG
- Daiichi Sankyo
Segment by Type
- OTC
- Rx Drugs
Segment by Application
- Hospital
- Drugs Store
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Infective Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Infective Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Anti-Infective Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Infective Drugs Market Perspective (2019-2030)
2.2 Anti-Infective Drugs Growth Trends by Region
2.2.1 Global Anti-Infective Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-Infective Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-Infective Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-Infective Drugs Market Dynamics
2.3.1 Anti-Infective Drugs Industry Trends
2.3.2 Anti-Infective Drugs Market Drivers
2.3.3 Anti-Infective Drugs Market Challenges
2.3.4 Anti-Infective Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Infective Drugs Players by Revenue
3.1.1 Global Top Anti-Infective Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-Infective Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Infective Drugs Revenue
3.4 Global Anti-Infective Drugs Market Concentration Ratio
3.4.1 Global Anti-Infective Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Drugs Revenue in 2023
3.5 Anti-Infective Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Infective Drugs Product Solution and Service
3.7 Date of Enter into Anti-Infective Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Infective Drugs Breakdown Data by Type
4.1 Global Anti-Infective Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-Infective Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-Infective Drugs Breakdown Data by Application
5.1 Global Anti-Infective Drugs Historic Market Size by Application (2019-2024)
5.2 Global Anti-Infective Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-Infective Drugs Market Size (2019-2030)
6.2 North America Anti-Infective Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-Infective Drugs Market Size by Country (2019-2024)
6.4 North America Anti-Infective Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Infective Drugs Market Size (2019-2030)
7.2 Europe Anti-Infective Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-Infective Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-Infective Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-Infective Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-Infective Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-Infective Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Infective Drugs Market Size (2019-2030)
9.2 Latin America Anti-Infective Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-Infective Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-Infective Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-Infective Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-Infective Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-Infective Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Anti-Infective Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Anti-Infective Drugs Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Anti-Infective Drugs Introduction
11.2.4 Merck Revenue in Anti-Infective Drugs Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anti-Infective Drugs Introduction
11.3.4 Pfizer Revenue in Anti-Infective Drugs Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Anti-Infective Drugs Introduction
11.4.4 Novartis AG Revenue in Anti-Infective Drugs Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Detail
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Anti-Infective Drugs Introduction
11.5.4 Gilead Sciences Revenue in Anti-Infective Drugs Business (2019-2024)
11.5.5 Gilead Sciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Anti-Infective Drugs Introduction
11.6.4 Abbott Revenue in Anti-Infective Drugs Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Detail
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Anti-Infective Drugs Introduction
11.7.4 Sanofi-Aventis Revenue in Anti-Infective Drugs Business (2019-2024)
11.7.5 Sanofi-Aventis Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Anti-Infective Drugs Introduction
11.8.4 Bristol-Myers Squibb Revenue in Anti-Infective Drugs Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Johnson
11.9.1 Johnson Company Detail
11.9.2 Johnson Business Overview
11.9.3 Johnson Anti-Infective Drugs Introduction
11.9.4 Johnson Revenue in Anti-Infective Drugs Business (2019-2024)
11.9.5 Johnson Recent Development
11.10 Roche Pharma AG
11.10.1 Roche Pharma AG Company Detail
11.10.2 Roche Pharma AG Business Overview
11.10.3 Roche Pharma AG Anti-Infective Drugs Introduction
11.10.4 Roche Pharma AG Revenue in Anti-Infective Drugs Business (2019-2024)
11.10.5 Roche Pharma AG Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Anti-Infective Drugs Introduction
11.11.4 Nanosphere Revenue in Anti-Infective Drugs Business (2019-2024)
11.11.5 Nanosphere Recent Development
11.12 NanoViricides
11.12.1 NanoViricides Company Detail
11.12.2 NanoViricides Business Overview
11.12.3 NanoViricides Anti-Infective Drugs Introduction
11.12.4 NanoViricides Revenue in Anti-Infective Drugs Business (2019-2024)
11.12.5 NanoViricides Recent Development
11.13 Novabay Pharmaceuticals
11.13.1 Novabay Pharmaceuticals Company Detail
11.13.2 Novabay Pharmaceuticals Business Overview
11.13.3 Novabay Pharmaceuticals Anti-Infective Drugs Introduction
11.13.4 Novabay Pharmaceuticals Revenue in Anti-Infective Drugs Business (2019-2024)
11.13.5 Novabay Pharmaceuticals Recent Development
11.14 Obetech
11.14.1 Obetech Company Detail
11.14.2 Obetech Business Overview
11.14.3 Obetech Anti-Infective Drugs Introduction
11.14.4 Obetech Revenue in Anti-Infective Drugs Business (2019-2024)
11.14.5 Obetech Recent Development
11.15 Optimer Pharmaceuticals
11.15.1 Optimer Pharmaceuticals Company Detail
11.15.2 Optimer Pharmaceuticals Business Overview
11.15.3 Optimer Pharmaceuticals Anti-Infective Drugs Introduction
11.15.4 Optimer Pharmaceuticals Revenue in Anti-Infective Drugs Business (2019-2024)
11.15.5 Optimer Pharmaceuticals Recent Development
11.16 Basilea Pharmaceutica AG
11.16.1 Basilea Pharmaceutica AG Company Detail
11.16.2 Basilea Pharmaceutica AG Business Overview
11.16.3 Basilea Pharmaceutica AG Anti-Infective Drugs Introduction
11.16.4 Basilea Pharmaceutica AG Revenue in Anti-Infective Drugs Business (2019-2024)
11.16.5 Basilea Pharmaceutica AG Recent Development
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Detail
11.17.2 Daiichi Sankyo Business Overview
11.17.3 Daiichi Sankyo Anti-Infective Drugs Introduction
11.17.4 Daiichi Sankyo Revenue in Anti-Infective Drugs Business (2019-2024)
11.17.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
